Top Markets
#1 Siren Siren +33.52%
#2 Wiki Cat Wiki Cat +25.95%
#3 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +17.28%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.15%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +16.59%
#7 Cysic Cysic +15.77%
#8 Bitway Bitway +15.75%
#9 The Grays Currency The Grays Currency +15.71%
#10 Wrapped Pulse Wrapped Pulse +15.37%
Coin of the day
Siren Siren
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Peringkat dalam Saham #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Harga Saham
$0.089
Terakhir disinkronkan: 2026-08-17
Kapitalisasi Pasar
$15.36M
Perubahan (1 hari)
50.59%
Perubahan (1 tahun)
111.85%
Negara
US
Perdagangan Inhibitor Therapeutics, Inc. (INTI)

Kategori

Healthcare
Laba untuk Inhibitor Therapeutics, Inc. (INTI)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Inhibitor Therapeutics, Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Inhibitor Therapeutics, Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE